PRKAA1 and infection: To address whether AMPKα1 contributes to secondary CD8 responses, control and AMPKα1null OT1 cells were cotransferred and recipient mice rechallenged with rLMOVA 3 weeks following primary infection and assessed for a recall response after a further 6 days.